Efficacy of Finasteride for Treating Patients with Androgenetic Alopecia who are Pileous in other Areas: A Pilot Study in Japan

被引:5
|
作者
Inadomi, Toru [1 ]
机构
[1] Ichikawa Rio Dermatol Clin, 3-1-20-1F Ichikawa Minami, Chiba 2720033, Japan
关键词
Androgenetic alopecia; finasteride; pilous;
D O I
10.4103/0019-5154.127677
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Androgenetic alopecia (AGA) involves androgen-dependent hair loss and finasteride is an established treatment for the disease. However, reports of the influence of finasteride on hair growth in other areas of the body are lacking. Aims: To investigate the effects of finasteride on hair, including the head and other areas of the body. Materials and Methods: Based on whether AGA patients felt they were pileous in areas other than the head, they were divided into Group A (pileous) or Group B (not pileous). Finasteride (1 mg/day) was prescribed for both groups for at least 6 months, after which patients were asked to estimate the medicine's effects and any changes of their hair growth. Results and Conclusions: A total of 18 out of 37 patients were placed in Group A and 19 of them were in Group B, suggesting that about half of AGA patients in Japan are pileous in other parts of the body. Oral finasteride was effective (excellent or good) in 22 out of 37 (59.5%) patients overall, in 16 out of 18 (88.9%) patients in Group A, and in 6 out of 19 (31.6%) patients in Group B. None of the patients reported that oral finasteride had any effect on their hair growth other than on their head. Finasteride is more effective for treating AGA patients who are pileous in other areas of the body.
引用
收藏
页码:163 / 165
页数:3
相关论文
共 50 条
  • [42] Efficacy and safety of indacaterol 150 and 300 μg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: A 12-week, placebo-controlled study
    Kinoshita, Masaharu
    Lee, Sang Haak
    Hang, Liang-Wen
    Ichinose, Masakazu
    Hosoe, Motoi
    Okino, Naoko
    Prasad, Niyati
    Kramer, Benjamin
    Fukuchi, Yoshinosuke
    RESPIROLOGY, 2012, 17 (02) : 379 - 389
  • [43] A randomized, double-blind, pilacebo-controlled, single-center pilot study to determine the efficacy of recombinant human interleukin IL-11 (neumega) in treating thrombocytopenia in burn patients
    Friedman, B
    Shaver, JR
    Hickerson, W
    Wilson, J
    Still, JM
    CHEST, 2003, 124 (04) : 181S - 181S
  • [44] Post-hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long-term study (Secondary Publication)
    Ishigooka, Jun
    Usami, Tomohiro
    Iwashita, Shuichi
    Kojima, Yoshitsugu
    Matsuo, Satoshi
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (02) : 122 - 129
  • [45] Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study
    Hashimoto, Naoki
    Toyomaki, Atsuhito
    Honda, Minoru
    Miyano, Satoru
    Nitta, Nobuyuki
    Sawayama, Hiroyuki
    Sugawara, Yasufumi
    Uemura, Keiichi
    Tsukamoto, Noriko
    Koyama, Tsukasa
    Kusumi, Ichiro
    ANNALS OF GENERAL PSYCHIATRY, 2015, 14
  • [46] Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan
    Hirasawa, Yosuke
    Adachi, Takahiro
    Hashimoto, Takeshi
    Fukuokaya, Wataru
    Koike, Yuhei
    Yata, Yuji
    Komura, Kazumasa
    Uchimoto, Taizo
    Tsujino, Takuya
    Nishimura, Kazuki
    Takahara, Kiyoshi
    Saruta, Masanobu
    Fujita, Kazutoshi
    Hashimoto, Mamoru
    Uemura, Hirotsugu
    Shiroki, Ryoichi
    Azuma, Takashi
    Kimura, Takahiro
    Ohno, Yoshio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (04)
  • [47] The efficacy and safety of lenvatinib in patients who did not meet the inclusion criteria of the phase III trial (REFLECT trial) and those with BCLC Stage B hepatocellular carcinoma: A nationwide multicenter study in Japan
    Sakamoto, A.
    Kurosaki, M.
    Tsuchiya, K.
    Abe, T.
    Ogawa, C.
    Soda, T.
    Kimura, H.
    Kondo, M.
    Tsuji, K.
    Koichiro, F.
    Shigeno, M.
    Jyoko, K.
    Narita, R.
    Uchida, Y.
    Yoshida, H.
    Akahane, T.
    Kobashi, H.
    Mitsuda, A.
    Marusawa, H.
    Izumi, N.
    ANNALS OF ONCOLOGY, 2019, 30 : 289 - 289
  • [49] Safety and efficacy of dronabinol treatment for weight loss in Alzheimer's disease (AD) patients taking acetylcholinesterase inhibitors who are resistant to megestrol: A three month pilot study in long term care facilities.
    Patel, S
    Shua-Haim, JR
    Pass, MD
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S44 - S44
  • [50] Peginterferon α-2a Combination Therapies in Chronic Hepatitis C Patients Who Relapsed After or Had a Viral Breakthrough on Therapy with Standard Interferon α-2b Plus Ribavirin: A Pilot Study of Efficacy and Safety
    Steven K. Herrine
    Robert S. Brown
    David E. Bernstein
    Michael S. Ondovik
    Ellen Lentz
    Helen Te
    Digestive Diseases and Sciences, 2005, 50 : 719 - 726